CDC's New Deputy Director Raises Concerns Over Anti-Vaccine Stance
The Centers for Disease Control and Prevention (CDC) has appointed Dr. Ralph Abraham, a member of Congress and former surgeon general of Louisiana, as its new principal deputy director. However, his appointment comes with a troubling record of anti-vaccine rhetoric and actions.
Abraham's past statements on vaccines have been characterized by misinformation and debunked claims. He has backed ineffective Covid-19 treatments like ivermectin and appears to align closely with Health Secretary Robert F. Kennedy Jr., a prominent anti-vaccine advocate. During his tenure as Louisiana surgeon general, Abraham ended a campaign to promote childhood vaccinations and failed to alert the public about whooping cough deaths in a timely manner.
This appointment raises concerns over the CDC's stance on vaccines and public health. Federal agencies like the CDC are at the center of an ongoing power struggle over vaccines, with Kennedy's anti-vaccine views seemingly clashing with more restrained officials. Abraham's record suggests that he will be a proponent of Kennedy's agenda, potentially further eroding confidence in America's public health agencies.
The appointment also highlights the growing divide between the CDC and other federal agencies on vaccine policy. The result has been a steady erosion of trust in the agency and more confusion and misinformation about vaccines.
In contrast, a recent development offers some optimism for global public health. A malaria vaccine is set to become cheaper, with prices dropping from $4 to $2.99 per dose. This change is expected to make a significant difference at scale, potentially helping 7 million children in the next five years.
The Centers for Disease Control and Prevention (CDC) has appointed Dr. Ralph Abraham, a member of Congress and former surgeon general of Louisiana, as its new principal deputy director. However, his appointment comes with a troubling record of anti-vaccine rhetoric and actions.
Abraham's past statements on vaccines have been characterized by misinformation and debunked claims. He has backed ineffective Covid-19 treatments like ivermectin and appears to align closely with Health Secretary Robert F. Kennedy Jr., a prominent anti-vaccine advocate. During his tenure as Louisiana surgeon general, Abraham ended a campaign to promote childhood vaccinations and failed to alert the public about whooping cough deaths in a timely manner.
This appointment raises concerns over the CDC's stance on vaccines and public health. Federal agencies like the CDC are at the center of an ongoing power struggle over vaccines, with Kennedy's anti-vaccine views seemingly clashing with more restrained officials. Abraham's record suggests that he will be a proponent of Kennedy's agenda, potentially further eroding confidence in America's public health agencies.
The appointment also highlights the growing divide between the CDC and other federal agencies on vaccine policy. The result has been a steady erosion of trust in the agency and more confusion and misinformation about vaccines.
In contrast, a recent development offers some optimism for global public health. A malaria vaccine is set to become cheaper, with prices dropping from $4 to $2.99 per dose. This change is expected to make a significant difference at scale, potentially helping 7 million children in the next five years.